Related references
Note: Only part of the references are listed.Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
Andras Perl
NATURE REVIEWS RHEUMATOLOGY (2016)
A case of lymphangioleiomyomatosis associated with endometrial cancer and severe systemic lupus erythematosus
Kensuke Suzuki et al.
BMC CANCER (2016)
mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation
Hu Zeng et al.
IMMUNITY (2016)
Increased 5-hydroxymethylcytosine in CD4+ T cells in systemic lupus erythematosus
Ming Zhao et al.
JOURNAL OF AUTOIMMUNITY (2016)
Coexistence of systemic lupus erythematosus, tuberous sclerosis and aggressive natural killer-cell leukaemia: coincidence or correlated?
M. Olde Bekkink et al.
LUPUS (2016)
TFH cells progressively differentiate to regulate the germinal center response
Jason S. Weinstein et al.
NATURE IMMUNOLOGY (2016)
Cellular and metabolic requirements of effector T cells
George C. Tsokos
NATURE REVIEWS RHEUMATOLOGY (2016)
Dysregulation of anergy-related factors involved in regulatory T cells defects in Systemic Lupus Erythematosus patients: Rapamycin and Vitamin D efficacy in restoring regulatory T cells
Leontina M. Banica et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2016)
CD163+M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis
Gregor Olmes et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Coincidence of tuberous sclerosis and systemic lupus erythematosus-a case report
Carmen Carrasco Cubero et al.
REUMATOLOGIA CLINICA (2016)
mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging
Andras Perl
COMPANION DIAGNOSTICS: FROM BIOMARKER IDENTIFICATION TO MARKET ENTRY (2015)
Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells
Qingyu Zeng et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Oxidative stress and Treg depletion in lupus patients with anti-phospholipid syndrome
Zhi-wei Lai et al.
CLINICAL IMMUNOLOGY (2015)
Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus
Yuxin Liu et al.
CLINICAL IMMUNOLOGY (2015)
The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells
John P. Ray et al.
IMMUNITY (2015)
The Methylcytosine Dioxygenase Tet2 Promotes DNA Demethylation and Activation of Cytokine Gene Expression in T Cells
Kenji Ichiyama et al.
IMMUNITY (2015)
Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin
Andras Perl et al.
METABOLOMICS (2015)
Normalization of CD4+ T cell metabolism reverses lupus
Yiming Yin et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus
Shuangyan Luo et al.
CLINICAL EPIGENETICS (2015)
Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus erythematosus
Nils Rother et al.
FRONTIERS IN IMMUNOLOGY (2015)
HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE
Tiffany N. Caza et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
The Histidine Transporter SLC15A4 Coordinates mTOR-Dependent Inflammatory Responses and Pathogenic Antibody Production
Toshihiko Kobayashi et al.
IMMUNITY (2014)
Mechanism of Metformin-dependent Inhibition of Mammalian Target of Rapamycin (mTOR) and Ras Activity in Pancreatic Cancer ROLE OF SPECIFICITY PROTEIN (Sp) TRANSCRIPTION FACTORS
Vijayalekshmi Nair et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance
Tomohiro Koga et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Akt-Dependent Enhanced Migratory Capacity of Th17 Cells from Children with Lupus Nephritis
Sudhir Kshirsagar et al.
JOURNAL OF IMMUNOLOGY (2014)
Mechanistic Target of Rapamycin Complex 1 Expands Th17 and IL-4+ CD4-CD8-Double-Negative T Cells and Contracts Regulatory T Cells in Systemic Lupus Erythematosus
Hiroshi Kato et al.
JOURNAL OF IMMUNOLOGY (2014)
Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome
Guillaume Canaud et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
TSC1 controls macrophage polarization to prevent inflammatory disease
Linnan Zhu et al.
NATURE COMMUNICATIONS (2014)
Low abundance of the matrix arm of complex I in mitochondria predicts longevity in mice
Satomi Miwa et al.
NATURE COMMUNICATIONS (2014)
Prevention of Murine Lupus Nephritis by Targeting Multiple Signaling Axes and Oxidative Stress Using a Synthetic Triterpenoid
Tianfu Wu et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Structure and Function of Renal Macrophages and Dendritic Cells From Lupus-Prone Mice
Ranjit Sahu et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity
Li Zhang et al.
CLINICAL IMMUNOLOGY (2013)
hsBAFF promotes proliferation and survival in cultured B lymphocytes via calcium signaling activation of mTOR pathway
Zhen Ke et al.
CYTOKINE (2013)
Rapamycin unbalances the polarization of human macrophages to M1
Alessia Mercalli et al.
IMMUNOLOGY (2013)
Tuberous Sclerosis and Fulminant Lupus in a Young Woman
Namrata Singh et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2013)
IL-17RA Is Essential for Optimal Localization of Follicular Th Cells in the Germinal Center Light Zone To Promote Autoantibody-Producing B Cells
Yanna Ding et al.
JOURNAL OF IMMUNOLOGY (2013)
The TSC-mTOR pathway regulates macrophage polarization
Vanessa Byles et al.
NATURE COMMUNICATIONS (2013)
CMV Late Phase-Induced mTOR Activation Is Essential for Efficient Virus Replication in Polarized Human Macrophages
M. Poglitsch et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Immunologic characteristics of intrarenal T cells: Trafficking of expanded CD8+ T cell β-chain clonotypes in progressive lupus nephritis
Robert Winchester et al.
ARTHRITIS AND RHEUMATISM (2012)
N-Acetylcysteine Reduces Disease Activity by Blocking Mammalian Target of Rapamycin in T Cells From Systemic Lupus Erythematosus Patients A Randomized, Double-Blind, Placebo-Controlled Trial
Zhi-Wei Lai et al.
ARTHRITIS AND RHEUMATISM (2012)
Aberrant Macrophages Mediate Defective Kidney Repair That Triggers Nephritis in Lupus-Susceptible Mice
Yasunori Iwata et al.
JOURNAL OF IMMUNOLOGY (2012)
Proliferation signal inhibitors in the treatment of lupus nephritis: Preliminary experience
Desmond Y. H. Yap et al.
NEPHROLOGY (2012)
Metabolic Alterations and Increased Liver mTOR Expression Precede the Development of Autoimmune Disease in a Murine Model of Lupus Erythematosus
Laia Vila et al.
PLOS ONE (2012)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
Greg M. Delgoffe et al.
NATURE IMMUNOLOGY (2011)
mTORC1 Senses Lysosomal Amino Acids Through an Inside-Out Mechanism That Requires the Vacuolar H+-ATPase
Roberto Zoncu et al.
SCIENCE (2011)
Expansion of Circulating T Cells Resembling Follicular Helper T Cells Is a Fixed Phenotype That Identifies a Subset of Severe Systemic Lupus Erythematosus
Nicholas Simpson et al.
ARTHRITIS AND RHEUMATISM (2010)
Activation of Mammalian Target of Rapamycin Controls the Loss of TCRζ in Lupus T Cells through HRES-1/Rab4-Regulated Lysosomal Degradation
David R. Fernandez et al.
JOURNAL OF IMMUNOLOGY (2009)
Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys
Jose C. Crispin et al.
JOURNAL OF IMMUNOLOGY (2008)
Rapamycin prevents the development of nephritis in lupus-pirone NZH/W F-1 mice
S. L. Lui et al.
LUPUS (2008)
Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus
David Fernandez et al.
ARTHRITIS AND RHEUMATISM (2006)
Egr-2 and Egr-3 are negative regulators of T cell activation
M Safford et al.
NATURE IMMUNOLOGY (2005)
Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus
P Gergely et al.
JOURNAL OF IMMUNOLOGY (2002)
Metabolic switches of T-cell activation and apoptosis
A Perl et al.
ANTIOXIDANTS & REDOX SIGNALING (2002)
FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction
BN Desai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex
J Moss et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Share Paper
